![]() |
Volumn 74, Issue SUPPL.2, 2007, Pages 45-48
|
Interactions of the public and private sectors in drug development: Boundaries to protect scientific values while preserving innovation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ARTICLE;
CONFLICT OF INTEREST;
COOPERATION;
DRUG INDUSTRY;
DRUG SCREENING;
ECONOMICS;
ETHICS;
GOVERNMENT REGULATION;
HUMAN;
MASS COMMUNICATION;
MEDICAL RESEARCH;
ORGANIZATION AND MANAGEMENT;
SCIENTIFIC MISCONDUCT;
UNITED STATES;
UNIVERSITY HOSPITAL;
ACADEMIC MEDICAL CENTERS;
ALABAMA;
BIOMEDICAL RESEARCH;
CONFLICT OF INTEREST;
COOPERATIVE BEHAVIOR;
DIFFUSION OF INNOVATION;
DRUG EVALUATION;
DRUG INDUSTRY;
GOVERNMENT REGULATION;
HUMANS;
PRIVATE SECTOR;
PUBLIC SECTOR;
SCIENTIFIC MISCONDUCT;
UNITED STATES;
|
EID: 34250195736
PISSN: 08911150
EISSN: None
Source Type: Journal
DOI: 10.3949/ccjm.74.Suppl_2.S45 Document Type: Article |
Times cited : (6)
|
References (7)
|